نتائج البحث - "etanercept"

1

Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study

المؤلفون: Ilan Green, Fadi Hassan, Mohammad E. Naffaa, Eugene Merzon, Avivit Golan-Cohen, Amir Saab, Ziv Paz

المصدر: Rheumatology International. 41:1905-1913

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca6185a025a3269717dfef1965dc8c8Test
https://doi.org/10.1007/s00296-021-04989-yTest

2

Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review

المؤلفون: Cengiz Korkmaz, Deniz Arik, Reşit Yıldırım, Suzan Saylisoy, Döndü Üsküdar Cansu

المصدر: Rheumatology International. 41:1845-1853

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91bf659838cd50eade9f8a2743312e27Test
https://doi.org/10.1007/s00296-021-04822-6Test

3

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

المؤلفون: Daniel Windschall, Kirsten Minden, Frank Weller-Heinemann, Franz Thiele, Ivan Foeldvari, Ariane Klein, Gerd Horneff, A. Hospach

المصدر: Rheumatology International

مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, Immunology, Observational Research, Biologics, Opportunistic Infections, Infections, Receptors, Tumor Necrosis Factor, Etanercept, Abatacept, 03 medical and health sciences, chemistry.chemical_compound, Biological Factors, 0302 clinical medicine, Tocilizumab, Rheumatology, Internal medicine, Germany, Adalimumab, medicine, Immunology and Allergy, Humans, Immunologic Factors, 030212 general & internal medicine, Registries, 030203 arthritis & rheumatology, Anakinra, Biological Products, business.industry, Interleukin-6, Tumor Necrosis Factor-alpha, Incidence, Odds ratio, Juvenile idiopathic arthritis, Infliximab, Arthritis, Juvenile, chemistry, Antirheumatic Agents, Immunoglobulin G, Cohort, Female, Safety, business, medicine.drug, Interleukin-1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1690b55f34c2cea5058075a682e55728Test
http://europepmc.org/articles/PMC7952348Test

4

Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years’ experience of a tertiary pediatric rheumatology center

المؤلفون: Nuray Aktay Ayaz, Figen Çakmak, Şerife Gül Karadağ, Mustafa Çakan, Hafize Emine Sönmez, Rahime Koç, Ayşe Tanatar

المصدر: Rheumatology International. 40:771-776

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64dd37c54f83168888c578e0b126007Test
https://doi.org/10.1007/s00296-019-04498-zTest

5

The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis

المؤلفون: Jelena Vojinovic, Milena Despotović, Mina Cvetković, Tatjana Jevtovic-Stoimenov, Vuk Milošević, Dusica Pavlovic, Dragana Lazarevic, Jelena Basic, Tatjana Cvetkovic, Gordana Susic

المصدر: Rheumatology International. 39:551-559

مصطلحات موضوعية: Male, musculoskeletal diseases, medicine.medical_specialty, Adolescent, Genotype, Immunology, Arthritis, Polymorphism, Single Nucleotide, Gastroenterology, Etanercept, 03 medical and health sciences, 0302 clinical medicine, Gene Frequency, Rheumatology, immune system diseases, Internal medicine, medicine, Humans, Immunology and Allergy, Genetic Predisposition to Disease, 030212 general & internal medicine, Child, skin and connective tissue diseases, Allele frequency, 030203 arthritis & rheumatology, biology, business.industry, Catalase, medicine.disease, Arthritis, Juvenile, 3. Good health, Methotrexate, Treatment Outcome, Antirheumatic Agents, Etiology, biology.protein, Drug Therapy, Combination, Female, Tumor Necrosis Factor Inhibitors, Gene polymorphism, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9206d620845f648dcc1fa7cc1e177880Test
https://doi.org/10.1007/s00296-019-04246-3Test

6

Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept

المؤلفون: Elena Generali, Carlo Alberto Scirè, Marinos Kallikourdis, Carlo Selmi, Greta Carrara, Alessandra Bortoluzzi, Gianluigi Condorelli

المساهمون: Generali, E, Carrara, G, Kallikourdis, M, Condorelli, G, Bortoluzzi, A, Scire, C, Selmi, C

المصدر: Rheumatology International. 39:239-243

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4351f6643c6125e4f0d6d802b21da548Test
https://doi.org/10.1007/s00296-018-4196-9Test

7

Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort

المؤلفون: Marcela Gondim Aguiar, Carlos Nobre Rabelo Junior, Joaquim Ivo Vasques Dantas Landim, Francisco Airton Castro Rocha, Leila Nascimento da Rocha, Hermano Alexandre Lima Rocha, Carolina Noronha Lechiu, Luiza Helena Acácio Costa, João Pedro Emrich Accioly

المصدر: Rheumatology International. 39:67-71

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912fee1d3e70c6ce5c06be5d151e723dTest
https://doi.org/10.1007/s00296-018-4128-8Test

8

Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using 'National Database of Health Insurance Claims and Specific Health Checkups of Japan'

المؤلفون: Yasuyuki Kamata, Seiji Minota

المصدر: Rheumatology International. 38:663-668

مصطلحات موضوعية: Male, Time Factors, Databases, Factual, Cost-Benefit Analysis, 030204 cardiovascular system & hematology, Etanercept, Arthritis, Rheumatoid, Drug Utilization Review, 0302 clinical medicine, Japan, Immunology and Allergy, Practice Patterns, Physicians', Child, media_common, Aged, 80 and over, education.field_of_study, Middle Aged, Treatment Outcome, Antirheumatic Agents, Child, Preschool, Rheumatoid arthritis, Female, medicine.drug, Adult, musculoskeletal diseases, medicine.medical_specialty, Adolescent, media_common.quotation_subject, Immunology, Population, Drug Costs, Young Adult, 03 medical and health sciences, Rheumatology, Internal medicine, medicine, Health insurance, Humans, Healthcare Disparities, education, Aged, 030203 arthritis & rheumatology, Biological Products, business.industry, Abatacept, Infant, Newborn, Infant, medicine.disease, Infliximab, Family medicine, Health Expenditures, Rheumatologists, business, Administrative Claims, Healthcare, Welfare

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3c83b8fdf4ba01be91a55348570ce0Test
https://doi.org/10.1007/s00296-017-3900-5Test

9

Maintenance of remission with combination etanercept–DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access

المؤلفون: Qi Shen, Sameer Kotak, Karel Pavelka, Radu Vasilescu, Mahboob Rahman, Evgeny Nasonov, Mustafa Al-Maini, Andrew Dinh, Ehab Mahgoub, Cristiano A. F. Zerbini, Dmitry Karateev, Ronald Pedersen, Nurullah Akkoc, Bonnie Vlahos

المصدر: Rheumatology International. 37:1469-1479

مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Time Factors, Combination therapy, Immunology, Severity of Illness Index, Drug Administration Schedule, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Rheumatology, immune system diseases, Internal medicine, medicine, Humans, Immunology and Allergy, 030212 general & internal medicine, skin and connective tissue diseases, Adverse effect, 030203 arthritis & rheumatology, Biological Products, medicine.diagnostic_test, business.industry, Remission Induction, Middle Aged, medicine.disease, Surgery, Regimen, Methotrexate, Treatment Outcome, Antirheumatic Agents, Erythrocyte sedimentation rate, Rheumatoid arthritis, Drug Therapy, Combination, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c970301a85571b50f5d25f95087fba98Test
https://doi.org/10.1007/s00296-017-3749-7Test

10

Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort

المؤلفون: Andrea Lo Monaco, Enrico Fusaro, Antonio Carletto, Ilaria Piazza, Colin Gerard Egan, Ennio Giulio Favalli, Giorgio Amato, Luca Quartuccio, Fausto Salaffi, Andrea Becciolini, Maurizio Benucci, Simone Parisi, Rosario Foti, A. Semeraro, Fulvia Ceccarelli, Fabrizio Conti

المصدر: Rheumatology international. 40(2)

مصطلحات موضوعية: musculoskeletal diseases, Adult, Male, medicine.medical_specialty, Immunology, Etanercept, Medication Adherence, Arthritis, Rheumatoid, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Adalimumab, Immunology and Allergy, Humans, 030212 general & internal medicine, Treatment Failure, skin and connective tissue diseases, Aged, Retrospective Studies, 030203 arthritis & rheumatology, business.industry, Drug Substitution, Arthritis, Psoriatic, Middle Aged, medicine.disease, Discontinuation, Concomitant, Rheumatoid arthritis, Antirheumatic Agents, Cohort, Female, Tumor Necrosis Factor Inhibitors, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e348a79fbf38e66407aad40fbc45279Test
https://pubmed.ncbi.nlm.nih.gov/31435754Test

تنقيح النتائج